NPPB and cancer: At 30 days, an abnormal troponin, an abnormal (NT-pro)BNP, and cancer were associated with an increased incidence of adverse events [RR 2.9 (95% PI 1.5–5.7), 3.3 (95% PI 1.6–7.1), and 2.7 (95% PI 1.4–5.2), respectively; Table 6].